01/13/2026
Remimazolam, a newer intravenous anesthetic agent, has gained attention in the medical community due to its unique pharmacological properties, such as rapid onset and short duration of action. As a benzodiazepine derivative, it provides sedation and anxiolysis, with a primary use in procedural sedation and general anesthesia.
Despite these promising features, there are several reasons why remimazolam may not be an ideal choice for every clinical situation, and anesthesiologists may decide against its use in favor of other anesthetic agents like propofol, midazolam, and thiopental.
Despite these promising features, there are several reasons against using remimazolam or may not be an ideal choice for every clinical...